Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials

The Lancet

Volumn 366, Issue 9503, 2005, Pages 2087-2106

  Abe, O ^a,bz   Abe, R ^a   Enomoto, K ^a   Kikuchi, K ^a,bz   Koyama, H ^a   Masuda, H ^a   Nomura, Y ^a,cl   Sakai, K ^a   Sugimachi, K ^a   Tominaga, T ^a   Uchino, J ^a   Yoshida, M ^a   Haybittle, J L ^b   Davies, C ^c,ag   Harvey, V J ^d   Holdaway, T M ^d   Kay, R G ^d   Mason, B H ^d   Forbes, J F ^e,bs   Wilcken, N ^e   Gnant, M ^f   Jakesz, R ^f   Ploner, M ^f   Yosef, H M A ^g   Focan, C ^h   Lobelle, J P ^h   Peek, U ⁱ   Oates, G D ^j   Powell, J ^j   Durand, M ^k   Mauriac, L ^k   Di Leo, A ^l   Dolci, S ^l   Piccart, M J ^l   Masood, M B ^m   Parker, D ^m   Price, J J ^m   Hupperets, P S G J ⁿ   Jackson, S ^o   Ragaz, J ^o   Berry, D ^p   Broadwater, G ^p   Cirrincione, C ^p   Muss, H ^p   Norton, L ^p,cf   Weiss, R B ^p   Abu Zahra, H T ^q   Portnoj, S M ^r   Baum, M ^s,cn   Cuzick, J ^s   Houghton, J ^s   Riley, D ^s   Mansel, R E ^t   Gordon, N H ^u   Davis, H L ^v   Beatrice, A ^w   Mihura, J ^w   Naja, A ^w   Lehingue, Y ^x   Romestaing, P ^x   Dubois, J B ^y   Delozier, T ^z   Mace Lesec'h, J ^z   Rambert, P ^aa   Petruzelka, L ^ab   Pribylova, O ^ab   Owen, J R ^ac   Harbeck, N ^ad   Janicke F ^ad   Meisner, C ^ad   Meier, P ^ae   Howell, A ^af   Ribeiro, G C ^af   Swindell, R ^af,cq   Burrett, J ^ag   Clarke, M ^ag   Collins, R ^ag   Darby, S ^ag   Elphinstone, P ^ag   Evans, V ^ag   Godwin, J ^ag   Gray, R ^ag,ao   Harwood, C ^ag   Hicks, C ^ag   Jackson, D ^ag   James, S ^ag   MacKinnon, E ^ag   McGale, P ^ag   McHugh, T ^ag   Mead, G ^ag   Morris, P ^ag   Oulds, J ^ag   Peto, R ^ag   Taylor, C ^ag   Wang, Y ^ag   Albano, J ^ah   De Oliveira, C F ^ah   Gervasio H ^ah   Gordilho, J ^ah   Johansen, H ^ai   Mouridsen, H T ^ai,ak   Gelman, R S ^aj   Harris, J R ^aj   Henderson, I C ^aj   Shapiro, C L ^aj   Christiansen, P ^ak   Ejlertsen, B ^ak   Moller S ^ak   Overgaard, M ^ak   Carstensen, B ^al   Palshof, T ^al   Trampisch, H J ^am   Dalesio, O ^an   De Vries, E G E ^an   Rodenhuis, S ^an   Van Tinteren, H ^an   Comis, R L ^ao   Davidson, N E ^ao   Robert, N ^ao   Sledge, G ^ao   Tormey, D C ^ao   Wood, W ^ao   Cameron, D ^ap   Chetty, U ^ap   Forrest, P ^ap   Jack, W ^ap   Rossbach, J ^aq   Klijn, J G M ^ar   Treurniet Donker, A D ^ar   Van Putten, W L J ^ar   Costa, A ^as   Veronesi, U ^as   Bartelink, H ^at   Duchateau, L ^at   Legrand, C ^at   Sylvester, R ^at   Van Der Hage, J A ^at   Van De Velde, C J H ^at   Cunningham, M P ^au   Catalano, R ^av   Creech, R H ^av   Bonneterre, J ^aw   Fargeot, P ^aw   Fumoleau, P ^aw   Kerbrat, P ^aw   Namer, M ^aw   Jonat, W ^ax   Kaufmann, M ^ax,bi   Schumacher, M ^ax,ay   Von Minckwitz, G ^ax   Bastert, G ^ay   Rauschecker, H ^ay   Sauer, R ^ay   Sauerbrei, W ^ay   Schauer, A ^ay   De Schryver, A ^az   Vakaet, L ^az   Belfiglio, M ^ba   Nicolucci, A ^ba   Pellegrini, F ^ba   Sacco, M ^ba   Valentini, M ^ba   McArdle, C S ^bb   Smith, D C ^bb   Galligioni, E ^bc   Boccardo, F ^bd   Rubagotti, A ^bd   Dent, D M ^be   Gudgeon, C A ^be   Hacking, A ^be,dj   Erazo, A ^bf   Medina, J Y ^bf   Izuo, M ^bg   Morishita, Y ^bg   Takei, H ^bg   Fentiman, I S ^bh   Hayward, J L ^bh   Rubens, R D ^bh   Skilton, D ^bh   Scheurlen, H ^bi   Von Fournier, D ^bi   Dafni, U ^bj   Fountzilas, G ^bj   Klefstrom, P ^bk   Blomqvist, C ^bl   Saarto, T ^bl   Margreiter, R ^bm   Asselain, B ^bn   Salmon, R J ^bn   Vilcoq, J R ^bn   Arriagada, R ^bo   Hill, C ^bo   Laplanche, A ^bo   Le M G ^bo   Spielmann, M ^bo   Bruzzi, P ^bp   Montanaro, E ^bp   Rosso, R ^bp   Sertoli, M R ^bp   Venturini, M ^bp   Amadori, D ^bq   Benraadt, J ^br   Kooi, M ^br   Van De Velde, A O ^br   Van Dongen, J A ^br   Vermorken, J B ^br   Castiglione, M ^bs,ds,dt   Cavalli, F ^bs   Coates, A ^bs   Collins, J ^bs   Gelber, R D ^bs   Goldhirsch, A ^bs,ds,dt   Lindtner, J ^bs   Price, K N ^bs   Rudenstam, C M ^bs   Senn, H J ^bs,ds,dt   Bliss, J M ^bt   Chilvers, C E D ^bt   Coombes, R C ^bt   Hall, E ^bt   Marty, M ^bt   Borovik, R ^bu   Brufman, G ^bu   Hayat, H ^bu   Robinson, E ^bu   Wigler, N ^bu   Bonadonna, G ^bv   Camerini, T ^bv   De Palo, G ^bv   Del Vecchio, M ^bv   Formelli, F ^bv   Valagussa, P ^bv   Martoni, A ^bw   Pannuti, F ^bw   Cocconi, G ^bx,da   Colozza, A ^bx   Camisa, R ^bx   Aogi, K ^by   Takashima, S ^by   Ikeda, T ^bz   Inokuchi, K ^bz   Sawa, K ^bz,cy   Sonoo, H ^ca   Korzeniowski, S ^cb   Skolyszewski, J ^cb   Ogawa, M ^cc   Yamashita, J ^cc   Bonte, J ^cd   Christiaens, R ^cd   Paridaens, R ^cd   Van Den Bogaert, W ^cd   Martin, P ^ce   Romain, S ^ce   Hakes, T ^cf   Hudis, C A ^cf   Wittes, R ^cf   Giokas, G ^cg   Kondylis, D ^cg   Lissaios, B ^cg   De La Huerta, R ^ch   Sainz, M G ^ch   Altemus, R ^ci   Cowan, K ^ci   Danforth, D ^ci   Lichter, A ^ci   Lippman, M ^ci   O'Shaughnessy, J ^ci   Pierce, L J ^ci   Steinberg, S ^ci   Venzon, D ^ci   Zujewski, J A ^ci   Paradiso, A ^cj   De Lena, M ^cj   Schittulli, F ^cj   Myles, J D ^ck   Pater, J L ^ck   Pritchard, K I ^ck,cw,dw,dx   Whelan, T ^ck,cw   Anderson, S ^cm   Bass, G ^cm   Brown, A ^cm   Bryant, J ^cm   Costantino, J ^cm   Dignam, J ^cm   Fisher, B ^cm   Redmond, C ^cm   Wieand, S ^cm   Wolmark, N ^cm   Jackson, I M ^cn   Palmer, M K ^cn   Ingle, J N ^co   Suman, V J ^co   Bengtsson, N O ^cp   Jonsson, H ^cp   Larsson, L G ^cp   Lythgoe, J P ^cq   Kissin, M ^cr   Erikstein, B ^cs,ct   Hannisdal, E ^cs   Jacobsen, A B ^cs,ct   Varhaug, J E ^cs   Gundersen, S ^ct   Hauer Jensen, M ^ct   Host H ^ct,dj   Nissen Meyer, R ^ct,dl   Blamey, R W ^cu   Mitchell, A K ^cu   Morgan, D A L ^cu   Robertson, J F R ^cu   Di Palma, M ^cv   Mathe G ^cv   Misset, J L ^cv   Clark, R M ^cw   Levine, M ^cw   Morimoto, K ^cx   Takatsuka, Y ^cy   Crossley, E ^cz   Harris, A ^cz   Talbot, D ^cz   Taylor, M ^cz   Di Blasio, B ^da   Ivanov, V ^db   Semiglazov, V ^db   Brockschmidt, J ^dc   Cooper, M R ^dc   Ueo, H ^dd   Falkson, C I ^de   A'Hern, R ^df   Ashley, S ^df   Powles, T J ^df   Smith, I E ^df   Yarnold, J R ^df   Gazet, J C ^dg   Corcoran, N ^dh   Deshpande, N ^di   Di Martino, L ^di   Douglas, P ^dj   Lindtner, A ^dj   Notter, G ^dj   Bryant, A J S ^dk   Ewing, G H ^dk   Firth, L A ^dk   Krushen Kosloski, J L ^dk   Foster, L ^dm   George, W D ^dm   Stewart, H J ^dm   Stroner, P ^dm   Malmstrom P ^dn   Moller T R ^dn   Ryden S ^dn   Tengrup, I ^dn   Tennvall Nittby, L ^dn   Carstenssen, J ^do   Dufmats, M ^do   Hatschek, T ^do   Nordenskjold B ^do   Soderberg M ^do   Carpenter, J T ^dp   Albain, K ^dq   Crowley, J ^dq   Green, S ^dq   Martino, S ^dq   Osborne, C K ^dq   Ravdin, P M ^dq   Glas, U ^dr   Johansson, U ^dr   Rutqvist, L E ^dr   Singnomklao, T ^dr   Wallgren, A ^dr   Maibach, R ^ds,dt   Thurlimann B ^ds,dt   Brenner, H ^du   Hercbergs, A ^du   Yoshimoto, M ^dv   DeBoer, G ^dw   Paterson, A H G ^dw   Meakin, J W ^dx   Panzarella, T ^dx   Shan, Y ^dy   Shao, Y F ^dy   Wang, X ^dy   Zhao, D B ^dy   Chen, Z M ^ag   Pan, H C ^ag   Bahi, J ^dz   Reid, M ^ea   Spittle, M ^ea   Deutsch, G P ^eb   Senanayake, F ^eb   Kwong, D L W ^eb   Bianco, A R ^ec   Carlomagno, C ^ec   De Laurentiis, M ^ec   De Placido, S ^ec   Buzdar, A U ^ed   Smith, T ^ed   Bergh, J ^ee   Holmberg, L ^ee   Liljegren, G ^ee   Nilsson, J ^ee   Seifert, M ^ef   Sevelda, P ^ef   Zielinsky, C C ^ef   Buchanan, R B ^eg   Cross, M ^eg   Royle, G T ^eg   Dunn, J A ^eh   Hills, R K ^eh   Lee, M ^eh   Morrison, J M ^eh   Spooner, D ^eh   Litton, A ^ei   Chlebowski, R T ^ej   Caffier, H ^ek   more..

^a ACETBC   (Japan)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c ATLAS Trial Collaborative Study Group   (United Kingdom)

^d Auckland Breast Cancer Study Group   (New Zealand)

^e Australian New Zealand Breast Cancer Trials Group   (Australia)

^f Austrian Breast Cancer Study Group   (Austria)

^g BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^h Belgian Adjuvant Breast Cancer Project   (Belgium)

ⁱ Berlin Brandenburgische Akademie der Wissenschaften   (Germany)

^j Birmingham General Hospital   (United Kingdom)

^k INSTITUT BERGONIÉ   (France)

^l JULES BORDET INSTITUTE   (Belgium)

^m BRADFORD ROYAL INFIRMARY   (United Kingdom)

ⁿ Maastricht UMC+ Comprehensive Cancer Centre   (Netherlands)

^o BRITISH COLUMBIA CANCER AGENCY   (Canada)

^p Cancer and Leukemia Group B   (United States)

^q CANCER CARE ONTARIO   (Canada)

^r INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^s IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^t Cardiff Trialists Group   (United Kingdom)

^u CASE WESTERN RESERVE UNIVERSITY   (United States)

^v Central Oncology Group   (United States)

^w INSTITUT CLAUDIUS REGAUD   (France)

^x CENTRE LÉON BÉRARD   (France)

^y CENTRE VAL D AURELLE   (France)

^z François Baclesse Institute   (France)

^aa CENTRE RENÉ HUGUENIN   (France)

^ab CHARLES UNIVERSITY   (Czech Republic)

^ac CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^ad Chemo N0 Trial Group   (Germany)

^ae UNIVERSITY OF CHICAGO   (United States)

^af CHRISTIE HOSPITAL   (United Kingdom)

^ag CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^ah Instituto Portugues de Oncologia Francisco Gentil Centro Regional de Oncologia de Coimbra SA   (Portugal)

^ai Back Center of Copenhagen   (Denmark)

^aj DANA FARBER CANCER INSTITUTE   (United States)

^ak Danish Breast Cancer Cooperative Group   (Denmark)

^al Danish Cancer Registry   (Denmark)

^am HEINRICH HEINE UNIVERSITY   (Germany)

^an Dutch Working Party for Autologous Bone Marrow Transplant in Solid Tumours   (Netherlands)

^ao Eastern Cooperative Oncology Group   (United States)

^ap Edinburgh Breast Unit   (United Kingdom)

^aq Diakonie Klinikum Hamburg   (Germany)

^ar ERASMUS MEDICAL CENTER   (Netherlands)

^as EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^at EORTC DATA CENTER   (Belgium)

^au EVANSTON HOSPITAL   (United States)

^av FOX CHASE CANCER CENTER   (United States)

^aw French Adjuvant Study Group (GFEA)   (France)

^ax German Adjuvant Breast Group (GABG)   (Germany)

^ay German Breast Cancer Study Group   (Germany)

^az GHENT UNIVERSITY HOSPITAL   (Belgium)

^ba GIVIO Interdisciplinary Group for Cancer Care Evaluation   (Italy)

^bb VICTORIA INFIRMARY   (United Kingdom)

^bc Gruppo Oncologico Clinico Cooperativo del Nord Est   (Italy)

^bd Gruppo Ricerca Ormono Chemio Terapia Adiuvante (GROCTA)   (Italy)

^be UNIVERSITY OF CAPE TOWN   (South Africa)

^bf HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Mexico)

^bg GUNMA UNIVERSITY   (Japan)

^bh GUY S HOSPITAL   (United Kingdom)

^bi UNIVERSITY OF HEIDELBERG   (Germany)

^bj Hellenic Cooperative Oncology Group   (Greece)

^bk Helsinki Deaconess Medical Centre   (Finland)

^bl UNIVERSITY OF HELSINKI   (Finland)

^bm UNIVERSITY OF INNSBRUCK   (Austria)

^bn INSTITUT CURIE   (France)

^bo INSTITUT GUSTAVE ROUSSY   (France)

^bp UNIVERSITY OF GENOA   (Italy)

^bq ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

^br Integraal Kankercentrum Amsterdam   (Netherlands)

^bs International Breast Cancer Study Group (Ludwig)   (Switzerland)

^bt CHARING CROSS HOSPITAL   (United Kingdom)

^bu Israel NSABC   (Israel)

^bv NATIONAL CANCER INSTITUTE   (Italy)

^bw Italian Cooperative Chemo Radio Surgical Group   (Italy)

^bx Italian Oncology Group for Clinical Research   (Italy)

^by Breast Cancer Study Group   (Japan)

^bz Japanese Foundation for Multidisciplinary Treatment of Cancer   (Japan)

^ca KAWASAKI MEDICAL SCHOOL   (Japan)

^cb INSTITUTE OF ONCOLOGY   (Poland)

^cc KUMAMOTO UNIVERSITY   (Japan)

^cd UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^ce Marseille Laboratoire de Cancerologie Biologique APM   (France)

^cf MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^cg METAXA CANCER HOSPITAL   (Greece)

^ch Mexican National Medical Center   (Mexico)

^ci NATIONAL CANCER INSTITUTE   (United States)

^cj NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^ck National Cancer Institute of Canada Clinical Trials Group   (Canada)

^cl NATIONAL KYUSHU CANCER CENTER   (Japan)

^cm NSABP Foundation Inc   (United States)

^cn Nolvadex Adjuvant Trial Organisation   (United Kingdom)

^co North Central Cancer Treatment Group Rochester   (United States)

^cp North Sweden Breast Cancer Group   (Sweden)

^cq North Western British Surgeons   (United Kingdom)

^cr NORTHWICK PARK HOSPITAL   (United Kingdom)

^cs Norwegian Breast Cancer Group   (Norway)

^ct OSLO UNIVERSITY HOSPITAL   (Norway)

^cu NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^cv Oncofrance   (France)

^cw MCMASTER UNIVERSITY   (Canada)

^cx Osaka City University   (Japan)

^cy OSAKA NATIONAL HOSPITAL   (Japan)

^cz CHURCHILL HOSPITAL   (United Kingdom)

^da Parma Hospital   (Italy)

^db N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^dc Piedmont Oncology Association   (United States)

^dd OITA PREFECTURAL HOSPITAL   (Japan)

^de UNIVERSITY OF PRETORIA   (South Africa)

^df ROYAL MARSDEN HOSPITAL   (United Kingdom)

^dg ST GEORGE S HOSPITAL   (United Kingdom)

^dh ST LUKE S HOSPITAL   (Ireland)

^di Sardinia Oncology Hospital A Businico   (Italy)

^dj SASIB International Trialists   (South Africa)

^dk SASKATCHEWAN CANCER AGENCY   (Canada)

^dl Scandinavian Adjuvant Chemotherapy Study Group   (Norway)

^dm Scottish Cancer Therapy Network   (United Kingdom)

^dn South Swedish Breast Cancer Group   (Sweden)

^do South East Sweden Breast Cancer Group   (Sweden)

^dp Alabama Breast Cancer Project   (United States)

^dq South West Oncology Group   (United States)

^dr Stockholm Breast Cancer Study Group   (Sweden)

^ds SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

^dt OSAKO   (Switzerland)

^du TEL AVIV UNIVERSITY   (Israel)

^dv CANCER INSTITUTE HOSPITAL   (Japan)

^dw Toronto Edmonton Breast Cancer Study Group   (Canada)

^dx PRINCESS MARGARET HOSPITAL   (Canada)

^dy PEKING UNION MEDICAL COLLEGE   (China)

^dz SALAH AZAIEZ INSTITUTE   (Tunisia)

^ea UK Multicentre Cancer Chemotherapy Study Group   (United Kingdom)

^eb UK/Asia Collaborative Breast Cancer Group   (United Kingdom)

^ec UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^ed UNIVERSITY OF TEXAS   (United States)

^ee Uppsala Örebro Breast Cancer Study Group   (Sweden)

^ef UNIVERSITY OF VIENNA   (Austria)

^eg Wessex Radiotherapy Centre   (United Kingdom)

^eh West Midlands Oncology Association   (United Kingdom)

^ei West of Scotland Breast Trial Group   (United Kingdom)

^ej Western Cancer Study Group   (United States)

^ek UNIVERSITY OF WÜRZBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; HEART DISEASE; HUMAN; INCIDENCE; LUNG CANCER; LYMPH NODE; MASTECTOMY; MEDICAL INFORMATION; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; THORAX WALL;

EID: 29144475553     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67887-7     Document Type: Article

References (33)

1. J Cuzick, H Stewart, R Peto Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer Cancer Treat Rep 71 1987 15 29
2. J Cuzick, H Stewart, L Rutqvist Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy J Clin Oncol 12 1994 447 453
3. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials N Engl J Med 333 1995 1444 1455
4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials Lancet 355 2000 1757 1770
5. B Fisher, S Anderson, J Bryant Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 2002 1233 1241
6. National Institutes of Health Consensus Development Panel National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000 J Natl Cancer Inst 93 2001 979 989
7. E Ceilley, R Jagsi, S Goldberg Radiotherapy for invasive breast cancer in North America and Europe: results of a survey Int J Radiat Oncol Biol Phys 61 2005 365 373
8. AB Nattinger, RG Hoffman, RT Kneusel, MM Schapira Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery Lancet 356 2000 1148 1153
9. R Arriagada, LE Rutqvist, A Mattsson, A Kramar, S Ratstein Adequate locoregional treatment for early breast cancer may prevent secondary dissemination J Clin Oncol 13 1995 2869 2878
10. M Overgaard, PS Hansen, J Overgaard Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy N Engl J Med 337 1997 949 955
11. M Overgaard, M-B Jensen, J Overgaard Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Lancet 353 1999 1641 1648
12. J Ragaz, IA Olivotto, JJ Spinelli Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial J Natl Cancer Inst 97 2005 116 126
13. V Vinh-Hung, C Verschraegen for the Breast Conserving Surgery Project Breast-conserving surgery with or without radiotherapy: pooled analysis for risks of ipsilateral breast tumor recurrence and mortality J Natl Cancer Inst 96 2004 115 121
14. SC Darby, P McGale, CW Taylor, R Peto Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries Lancet Oncol 6 2005 557 565
15. ZA Carr, CE Land, RA Kleinerman Coronary heart disease after radiotherapy for peptic ulcer disease Int J Radiat Oncol Biol Phys 61 2005 842 850
16. M Deutsch, SR Land, M Begovic The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06 Cancer 98 2003 1362 1368
17. LJ Solin, BL Fowble, KL Martz, RL Goodman, GE Hanks Results of the 1983 patterns of care process survey for definitive breast irradiation Int J Radiat Oncol Biol Phys 20 1991 105 111
18. B Shank, J Moughan, J Owen, F Wilson, GE Hanks The 1993-94 patterns of care process survey for breast irradiation after breast-conserving surgery: comparison with the 1992 standard for breast conservation treatment Int J Radiat Oncol Biol Phys 48 2000 1291 1299
19. A Taghian, R Jagsi, A Makris Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: practice is culture driven rather than evidence based Int J Radiat Oncol Biol Phys 60 2004 706 714
20. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 2005 1687 1717
21. D Krag, T Ashikaga The design of trials comparing sentinel-node surgery and axillary resection N Engl J Med 349 2003 603 605
22. R Arriagada, MG Lê, J-M Guinebretiere, A Dunant, F Rochard, T Tursz Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients Ann Oncol 14 2003 1617 1622
23. H Bartelink, J-C Horiot, P Poortmans Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation N Engl J Med 345 2001 1378 1387
24. ER Fisher, S Anderson, E Tan-Chui, B Fisher, L Eaton, N Wolmark Fifteen-year prognostic discriminants for invasive breast carcinoma. National Surgical Adjuvant Breast and Bowel Project Protocol B-06 Cancer 91 suppl 8 2001 1679 1687
25. AC Voogd, M Nielsen, JL Peterse Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials J Clin Oncol 19 2001 1688 1697
26. JD Boice Jr, EB Harvey, M Blettner, M Stovall, JT Flannery Cancer in the contralateral breast after radiotherapy for breast cancer N Engl J Med 326 1992 781 785
27. HH Storm, M Andersson, JD Boice Jr Adjuvant radiotherapy and risk of contralateral breast cancer J Natl Cancer Inst 84 1992 1245 1250
28. VR Kini, FA Vicini, SJ Victor, CF Dmuchowski, M Rebner, AA Martinez Impact of the mode of detection on outcome in breast cancer patients treated with breast-conserving therapy Am J Clin Oncol 22 1999 429 435
29. LJ Pierce, J Moughan, J White, DP Winchester, J Owen, JF Wilson 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer Int J Radiat Oncol Biol Phys 62 2005 183 192
30. SA Fuller, JL Haybittle, REA Smith, HJ Dobbs Cardiac doses in post-operative breast irradiation Radiother Oncol 25 1992 19 24
31. J Ragaz, SM Jackson, N Le Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer N Engl J Med 337 1997 956 962
32. TJ Whelan, J Julian, J Wright, AR Jadad, ML Levine Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis J Clin Oncol 18 2000 1220 1229
33. LJ Kinlen Richard Doll, epidemiologist extraordinary Nature 438 2005 41